Home » FDA APPROVES SALIX'S OSMOPREP
FDA APPROVES SALIX'S OSMOPREP
The FDA has approved Salix Pharmaceuticals' colon-cleansing drug OsmoPrep tablets for use in preparation of colonoscopy in adults 18 years or older.
OsmoPrep (sodium phosphate monobasic monohydrate/sodium phosphate dibasic anhydrous) is patent protected until 2013. Additional patent protection is being sought through 2024.
KEYWORDS Drug Pipeline Alert
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May